Annals of medical malpractice

Jacob, Harry S.
March 2008
Hem/Onc Today;3/10/2008, Vol. 9 Issue 4, p3
The author discusses the medical malpractice case of an 11-year-old boy who was severely injured by a falling tree branch and was administered with a low-dose anticoagulation, twelve hours after admission. The author cites items of probable medical negligence that underlie the outcome of the patient's case.


Related Articles

  • Materials: Plants inspire medical coating.  // Nature;10/16/2014, Vol. 514 Issue 7522, p276 

    The article discusses invention of an anti-blood coagulation two-layer coating from carnivorous pitcher plant which could be used for medical implants.

  • A NEW ANTICOAGULANT.  // Canadian Medical Association Journal;9/21/1968, Vol. 99 Issue 11, p560 

    The article focuses on the discovery of an anticoagulant agent called Arvin. The anticoagulant causes a lowering of plasma fibrinogen by converting it to a fibrin-like substance which is precipitated as micro clots intravascularly. It also notes the limitation in the clinical use of Arvin in...

  • Out and about faster. Gutfeld, Greg; Meyers, Melissa; Sangiorgio, Maureen // Prevention;Nov90, Vol. 42 Issue 11, p19 

    Reports on shorter hospital treatment for blood clots. Shorter heparin therapy yields same results.

  • MEDICINES CO.  // MondayMorning;2/25/2013, Vol. 21 Issue 7, p1 

    The article offers information on the increment in the quarterly sales and revenue of the drug maker company Medicines Co. It mentions that revenue of the company has been increased due to rise in the sales of its injectable blood thinner Angiomax. It also mentions that company is planning to...

  • Fragmin. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p322 

    A definition of the term "Fragmin" is presented. It refers to a brand name for dalteparin, which is a low molecular weight heparin. Heparin is an anticoaulant drug that is used in the prevention and treatment of abnormal blood clotting.

  • MedEconomics: Near Patient Testing - Improving warfarin monitoring. Kelly, Anthony // GP: General Practitioner;12/10/2010, p38 

    The article reports on the community schemes set up by three practices in Worcestershire, England, to improve warfarin monitoring. The Spa Medical Practice, and the other two practices in Droitwich, Worcestershire, run a town-wide service for patients on warfarin and have appointed a specialist...

  • WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT XARELTO.  // Biotech Equipment Update;Aug2012, Vol. 20 Issue 8, p3 

    The article offers information about XARELTO (rivaroxaban), an oral anticoagulant. It states that people who take XARELTO for atrial fibrillation lower their chance of having a stroke by helping to prevent clots from forming. However, indicates that XARELTO can cause bleeding and rarely may lead...

  • New Blood Thinners Look Promising.  // Focus on Healthy Aging;May2013, Vol. 16 Issue 5, p1 

    The article focuses on the new non-warfarin blood thinners with evidence of low stroke incidents and intracranial bleeds. It says that patients who are developing blood clots are taking warfarin because it is the only oral anticoagulant drug as of 2010. Doctor Jonathan Halperin states that...

  • Thrombocytopenia Associated with Antithrombotic Therapy in Patients with Cardiovascular Diseases: Diagnosis and Treatment. Kilickiran Avci, Burcak; Oto, Ali; Ozcebe, Osman // American Journal of Cardiovascular Drugs;2008, Vol. 8 Issue 5, p327 

    Agents with antiplatelet and anticoagulant activity have been proved to be effective in reducing the incidence of complications following acute coronary syndrome, percutaneous coronary intervention, and cardiopulmonary bypass. However, these agents, including heparin, glycoprotein IIb/IIIa...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics